MF

Michael Allen Flynn

AP Aerpio Pharmaceuticals: 3 patents #2 of 10Top 20%
EP Eyepoint Pharmaceuticals: 2 patents #5 of 22Top 25%
AT Aerpio Therapeutics: 1 patents #10 of 19Top 55%
📍 Ann Arbor, MI: #1,436 of 6,071 inventorsTop 25%
🗺 Michigan: #15,670 of 86,293 inventorsTop 20%
Overall (All Time): #802,800 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
12145986 Method of treating an ocular condition by administering a humanized monoclonal antibodies that target VE-PTP (HPTP-Beta) Kevin Peters 2024-11-19
11180551 Humanized monoclonal antibodies that target VE-PTP (HPTP-beta) Kevin Peters 2021-11-23
11136389 Humanized monoclonal antibodies that target VE-PTP (HPTP-β) Kevin Peters 2021-10-05
10604569 Humanized monoclonal antibodies that target protein tyrosine phosphatase-beta (HPTP-β/VE-PTP) Kevin Peters 2020-03-31
10597452 Methods of treating ocular conditions by administering humanized monoclonal antibodies that target VE-PTP (HPTP-beta) Kevin Peters 2020-03-24
10253094 Antibodies that target human protein tyrosine phosphatase-beta (HPTP-beta) and methods of use thereof to treat ocular conditions Kevin Peters 2019-04-09